Presentation NY Valves 2024 How to Mitigate the Risk of Conduction Abnormalities Presenter: Samir R. Kapadia June 06, 2024
Presentation NY Valves 2024 Coronary Obstruction Risk Assessment as Part of Lifetime Management Considerations Presenter: Hasan Jilaihawi June 05, 2024
News Daily News Patient Decision Aid Improves Shared Decision-making in Aortic Stenosis Yael L. Maxwell May 28, 2024
News Conference News EuroPCR 2024 Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY Michael O'Riordan May 17, 2024
News Conference News EuroPCR 2024 Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids Michael O'Riordan May 15, 2024
News Conference News EuroPCR 2024 Debate Continues on TAVI Choice for Women With Small Annuli Yael L. Maxwell May 14, 2024
News Conference News TAVI Use Rising in Young US Patients, Yet Another Analysis Shows Yael L. Maxwell May 06, 2024
News Daily News Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups Michael O'Riordan April 17, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2024 Shelley Wood April 03, 2024
News Daily News Pay Now, Save Later: Intracoronary Imaging for PCI Cost-effective Over Lifetime Yael L. Maxwell March 18, 2024
News Daily News High Lp(a) Levels Harmful in Patients With and Without ASCVD Michael O'Riordan February 27, 2024
News Daily News Alcohol’s Impact on IHD Mortality Hinges on Socioeconomic Status Caitlin E. Cox February 07, 2024
News Conference News STS 2024 SAVR After Failed TAVI on the Rise, With High Mortality Yael L. Maxwell February 05, 2024
News Daily News Universal Risk Tool Works Well in Both Primary and Secondary Prevention Michael O'Riordan February 01, 2024
News Daily News High Systolic BP, LDL at a Young Age Matter Later in Life Caitlin E. Cox December 26, 2023
News Daily News Who Benefits Most From Semaglutide and How Long Will That Take? Shelley Wood December 19, 2023
News Daily News ‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults Michael O'Riordan November 21, 2023
News Conference News AHA 2023 Large, Sustained Reductions in Lp(a) With Lepodisiran in Phase I Study Michael O'Riordan November 13, 2023